Status:
COMPLETED
Nalbuphine for the Treatment of Opioid Induced Pruritus in Children
Lead Sponsor:
University of British Columbia
Conditions:
Pruritis
Eligibility:
All Genders
Up to 7 years
Phase:
PHASE3
Brief Summary
Itching is a frequent and disturbing side effect of the use of pain medication such as morphine. In the post-operative period, it can be more distressing to pediatric patients than their pain. The cur...
Detailed Description
PURPOSE Primary To determine the efficacy of nalbuphine (50 - 100 mcg/kg intravenously) in the treatment of opioid induced pruritus in a multi-center tertiary care pediatric patient population. Secon...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Postoperative morphine administration
Exclusion
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2004
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT00323154
Start Date
March 1 2004
End Date
December 1 2004
Last Update
September 25 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
British Columbia's Children's Hospital
Vancouver, British Columbia, Canada